Extensive genital bowenoid papulosis responding to imiquimod [8]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 1, 2007, Pages 113-115

  Ricart, J M ^a,b   Cordoba, J ^a   Hernandez, M ^a   Esplugues, I ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Department of Microbiology ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; IMIQUIMOD; VIRUS DNA;

ACANTHOSIS; ADULT; BODY MASS; BOWENOID PAPULOSIS; CASE REPORT; CLITORIS; CREAM; DERMIS; DNA EXTRACTION; FEMALE; FOLLOW UP; GENITAL SYSTEM DISEASE; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; INFLAMMATORY CELL; LETTER; PAPILLOMATOSIS; PLASMA CELL; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; ADULT; AMINOQUINOLINES; FEMALE; GENITAL DISEASES, FEMALE; HUMANS;

EID: 33845662328     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01801.x     Document Type: Letter

References (3)

1. Goorney BP, Polori R. A case of Bowenoid papulosis of the penis successfully treated with topical imiquimod cream 5%. Int J STD AIDS 2004; 15: 833-835.
2. Majewski S, Marczak M, Mlynarczyk B, Benninghoff B, Jablonska S. Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis. Int J Dermatol 2005; 44: 14-19.
3. Hama N, Ohtsuka T, Yamazaki S. Elevated amount of human papillomavirus 31 DNA in a squamous cell carcinoma developed from bowenoid papulosis. Dermatology 2004; 209: 329-332.